舒经汤治疗痛经及对患者血液流变学的影响

目的探讨舒经汤治疗原发性痛经的疗效及安全性。方法将62例原发性痛经患者随机分为3组,其中治疗组21例(口服舒经汤)、中药对照组21例(口服痛经宝颗粒)、西药对照组20例(口服双氯芬酸),观察各组的临床疗效、血液流变学变化及不良反应。结果治疗组、中药对照组及西药对照组的总有效率分别为95.2%、90.5%及77.8%。治疗前治疗组的血浆粘度(1.60±0.23)mPa·s,纤维蛋白原(4.40±1.18)g/L,均值略高于健康组,其中血沉均值与健康组比有非常显著差异(P<0.01)。而治疗后血浆粘度(1.34±0.18)mPa·s,纤维蛋白原(3.32±1.27)g/L,均值与健康组比无差异,其中血沉与健康组比较无显著性差异(P>0.05)。治疗组和中药对照组均未见明显不良反应,西药对照组主要表现为消化道反应。结论舒经汤治疗原发性痛经疗效确定,且远期疗效及安全性均优于西药对照组。     

温经化瘀合剂临床疗效观察与研究

目的:验证"温经化瘀舍剂"对妇女寒凝血瘀型痛经的治疗效果;方法:将符合中医诊断标准寒凝血瘀型痛经患者,随机分为2组,分别给予"温经化瘀合剂"和"痛经宁冲剂"进行治疗;结果:治疗组总有效率达95%,对照组总有效率80.5%,治疗组优于对照组,治疗组痊愈率48.3%,对照组痊愈率14.6%,治疗组明显优于对照组.实验动物无明显急性毒性反应,能减轻二甲苯引起的小鼠耳肿胀度,减少缩宫素所致大鼠扭体反应次数,和前列腺素E1所致小鼠扭体反应次数,对大鼠离体子宫有双向调节作用,证明"温经化瘀舍剂"具有镇痛、抗炎作用.     

Behavioral treatment parameters with primary dysmenorrhea

Fourteen women with primary dysmenorrhea were administered four sessions of systematic desensitization (SD) by either a male or a female therapist. The following measures were taken during the flow periods before and after treatment and at a 6-month follow-up: menstrual symptom checklist, medication usage, invalid hours, and menstrual attitudes. At pretreatment, menstrually distressed women had significantly higher scores on all measures compared to a normative group and an explicitly nondistressed group. At posttreatment, treated women's scores on the dependent variables were significantly reduced. All indices were reduced to a nondistressed level at posttreatment and at 6-month follow-up. Type of dysmenorrhea (congestive vs. spasmodic), trait anxiety level, and therapist sex did not predict differential responsiveness to SD. SD did not affect frontalis EMG, peripheral blood flow, or pain threshold. A Retrospective Symptom Scale of menstrual distress was found to be highly reliable, valid, and sensitive.     

天津市女大学生原发性痛经的现状及影响因素分析

目的 了解天津市女大学生原发性痛经的现状,探讨其影响因素。方法 2016年3月—2017年3月,以天津3所医学类院校和3所非医学类院校的女大学生作为研究对象,采用方便抽样的方法,发放自填式问卷进行调查。结果 在被调查的940名天津市在校女大学生中,原发性痛经的发生率为45.3%,其中,医学生(42.2%)与非医学生(49.5%)比较(χ2=5.009,P=0.025),两组之间痛经发生率的差异有统计学意义。多因素分析显示,年龄大、非医学专业、经期着凉、经期久坐不动与原发性痛经明显相关(P<0.05)。结论 原发性痛经在天津市在校女大学生中具有较高的发生率,与经期的不良行为习惯有关,应在大学生群体中积极开展月经期保健知识的健康教育。     

针灸治疗原发性痛经68例临床观察

采用针刺配隔姜灸治疗原发性痛经 6 8例 ,总有效率 97.0 6 % ,与药物对照组相比 ,P<0 .0 1 ,说明针灸治疗组疗效明显优于药物对照组     

634名女大学生痛经情况调查分析

目的 了解原发性痛经在高校女生中的发生情况及其相关因素。方法 采用调查表和妇科问诊两种方法对６３４名在校女大学生进行调查分析。结果 原发性痛经的发生率为３１．５５％。结论 情绪变化是痛经的主要诱发因素。     

经络输声疗法对原发性痛经的经络调整作用

本文以月经相关经脉的声传导的变化为观察指标，通过经络输声疗法对８２例原发性痛经治疗效果的观察，以验证经络输声疗法对经络的调整作用。将８２例原发性痛经随机分为３组，分别用３个频率治疗，进行对比分析。临床结果表明：经３个月经周期的治疗，痛经症状积分明显下降；月经血色、血量、血块趋于正常；总有效率为９６．４３％；对虚实证均有效，但其输声频率的选择有差异。说明经络输声疗法对经络有疏通、调节作用。实验结果表明：经络输声能改变原发性痛经相关经脉的声传导状态，治疗后经络导声恢复正常，证实了经络输声对经络的调整作用。从客观上显示了有关经络的病理及愈复变化。此项研究国内外尚无报道。     

活血化瘀法治疗青春期痛经临床观察

观察活血化瘀药物－痛经冲剂对痛经的疗效，探讨痛经的病理生理改变。方法；用积分法观察痛经疗效，并用彩色多普勒超声诊断仪测量子宫动脉血流参数，用锥板式粘度计量血液流变学指标并与健康者比较。结果：痛经患者子宫动脉血流参数搏动指数，阻力指数，收缩期峰值／舒张期峰值均显著高于健康人组，经痛经冲剂治疗后上述参数数值明显下降。     

黑莴豆汤治疗原发性痛经60例疗效颜察

目的：观察黑莴豆汤治疗痛经的临床疗效。方法：对60例原发性虚寒型痛经患者运用黑莴豆汤随月经周期服用治疗，3个月经周期后统计疼痛情况的变化。结果：痊愈49例，显效7例，有效4例，无效0例，痊愈率为81．7％，愈显率为93．3％，总有效率为100％。结论：黑莴豆汤随月经周期服用治疗痛经有较好的临床疗效。     

Effects of Electroacupuncture and Electroacupuncture Plus Tao Hong Si Wu Wan in Treating Primary Dysmenorrhea

This study investigated the efficacies of electroacupuncture and electroacupuncture combined with Tao Hong Si Wu Wan in treating primary dysmenorrhea and compared the results with those obtained using conventional medical treatment. One treatment group, group 1, was administered Tao Hong Si Wu Wan (2625 mg) while the other, group 2, was administered a placebo (2625 mg) twice daily for 3 months. Electroacupuncture was used in both treatment groups: two sessions per menstrual cycle for three menstrual cycles. The reference group, group 3, was administered ibuprofen, 600 mg, twice daily, for five menstrual cycles. Uses of the herb, placebo and ibuprofen were blinded. A ridit analysis was used for testing and interpreting the effects of treatment. Pain intensity was determined using a qualitative grading method in a blinded manner. The ridit scores in groups 1 and 2 were significantly higher than those in reference group immediately after treatment and three months later. Twelve months after the treatment, group 1 had a higher ridit score than group 2. In comparison to the reference group, groups 1 and 2 achieved better menstrual pain relief both immediately and 3 months after treatment. In addition, group 1 had better long-term pain relief than group 2.